611 - Bold Upgrades, Zero Downtime: How Smart Labs Are Modernising Pathology

Why It Matters

Modernizing pathology through incremental, AI‑driven integration mitigates risk, sustains critical diagnostic capacity, and meets growing consumer expectations, directly impacting healthcare efficiency and patient outcomes.

Key Takeaways

• Pathology workforce aging; 2,500 pathologists average age 50‑55
• 70% of clinical decisions rely on pathology tests
• Legacy LIMS from 1990s cause fragmentation and delays
• Labflow offers low‑code AI layer to integrate existing systems
• Incremental modernization reduces risk, improves accuracy, and adds revenue

Summary

The Talking Health Tech podcast episode focuses on how Magentus and its newly acquired Labflow are tackling the modernization of pathology labs amid rising consumer demand and an aging workforce. Dan Burke outlines Magentus’ long‑standing health‑software background, while Ben Richardson explains Labflow’s rapid rise during COVID to meet direct‑to‑consumer testing needs.

Key data points reveal a staggering half‑billion pathology tests performed annually in Australia by roughly 2,500 pathologists whose average age sits between 50 and 55. With 15‑year training cycles and impending retirements, the sector faces a workforce crunch, while 70% of clinical decisions depend on pathology results, heightening the urgency for digital and AI solutions.

Burke notes, “When it works well, you don’t see it,” emphasizing the hidden cost of fragmented legacy LIMS built in the 1990s. Richardson highlights Labflow’s low‑code, AI‑empowered logic platform that plugs into existing databases, enabling real‑time data manipulation and seamless interoperability without massive overhauls.

The discussion concludes that incremental, plug‑in modernization offers a safer, cost‑effective path forward, delivering new revenue streams, reducing human error, and improving patient outcomes while navigating regulatory scrutiny and diverse stakeholder demands.

Original Description

In this episode of Talking HealthTech, Peter Birch sits down with Dan Burke, Managing Director at Magentus, and Ben Richardson, CEO at Labflow, for a wide-ranging conversation about the state of pathology in Australia and the broader Asia-Pacific region.

With half a billion pathology tests processed in Australia every year and a workforce of only 2,500 pathologists, the sector is under significant pressure.

Dan and Ben unpack what that means for labs trying to modernise without disrupting the critical services that clinicians and patients depend on every day.

The discussion covers the growing role of artificial intelligence in diagnostic settings, exploring where AI is already delivering practical value and where human oversight remains non-negotiable.

The episode also digs into the challenge of legacy technology, making the case for incremental, modular modernisation over risky large-scale overhauls that can put operations at risk.

Beyond the technology, the conversation explores how consumer expectations are reshaping pathology, from the direct-to-consumer testing boom across Asia-Pacific markets to the rise of genomics and personalised medicine.

Key Takeaways

🔬 The pathology sector in Australia faces a significant workforce shortage and increasing test complexity, putting pressure on digital transformation in labs

🧩 Incremental modernisation and interoperability are addressed as more practical than full system replacements for pathology lab infrastructure

🧑‍⚕️ AI in diagnostics is positioned as a support tool for clinicians and administrative workflows, rather than replacing human experts

🌏 Consumer-driven demand, particularly in APAC markets like India and Malaysia, is accelerating digital adoption and expectations for health data access

🧬 The falling cost of genomics and genetics is setting the stage for personalised preventive healthcare and more targeted diagnostics

Timestamps

00:00 - Introductions & episode overview

00:54 - What is Magentus?

01:55 - The origin of Lab Flow

03:48 - The pathology landscape in 2026

08:42 - Fragmentation & technology challenges

13:58 - Incremental modernisation explained

17:38 - Interoperability & complexity in labs

19:05 - Role of AI in laboratory services

25:57 - Social perspectives on AI in healthcare

29:25 - Genomics, personalisation, and the future

Check out the episode and full show notes on the Talking HealthTech website.

If you’re enjoying the show and want access to exclusive healthtech discussions, meetups, and member-only content, you can learn more about becoming a THT+ Solo Member here: talkinghealth.tech/solo_shownotes

And if this episode was useful, leaving a review or sharing it with someone in the industry always helps.